HBV and HCV chronic hepatitis and cirrhosis

Research in Virology

Volumn 148, Issue 2, 1997, Pages 135-138

  Piccinino, F ^a   Scolastico, C ^a   Glielmo, A ^a   Piccinino, R ^a   Sagnelli, E ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

chronic disease; cirrhosis; HBV; HCV; hepatitis; review

Indexed keywords

INTERFERON;

CHRONIC HEPATITIS; CONFERENCE PAPER; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CIRRHOSIS; PRIORITY JOURNAL;

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

EID: 0030983777     PISSN: 09232516     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-2516(97)89898-6     Document Type: Conference Paper

References (29)

1. Alberti, A., Bortolotti, F., Tremolada, F. et al. (1992), Storia naturale dell'epatite di tipo C. Ligand Quarterly, 11, 2, 190.
2. Alter, H.J., Margolis, H.S., Krawczynsky, K. et al. (1992), The natural history of community acquired hepatitis C in the United States. N. Engl. J. Med., 327, 1899.
3. Brunetto, M.R., Stemler, M., Schodel, F. et al. (1989), Identification of HBV variants which cannot produce pre-core derived HBeAg and may be responsible for severe hepatitis. Ital. J. Gastroenterol., 21, 151.
4. Chemello, L., Alberti, A., Rose, K. & Simmonds, P. (1994), Hepatitis C serotype and response to IFN therapy. N. Engl. J. Med., 330, 143.
5. Chemello, L., Bonetti, P., Cavalletto, L. et al. (1995), Randomized trial comparing three different regimens of alpha-2a-interferon in chronic hepatitis C. Hepatology, 22, 700-706.
6. De Bac, C. (1994), La cirrosi virale, in "L'interferone nelle epatiti croniche" (Piccinino F., Sagnelli E., Felaco F.M., Giusti, G.) (pp. 223-231). CNR Progetto FATMA, Rotoform Roma.
7. Dusheiko, G., Schlimovitz-Weiss, H., Brown, D. et al. (1994), Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease. Hepatology, 19, 12-18.
8. Felaco, F.M., Aprea, L., Messina, V. et al. (1994), Effect of a 24 month alpha IFN treatment in HCV chronic hepatitis. J. Hepatol., 21, S105.
9. Galanti, B., Nardiello, S., Russo, M. (1992), Epatite cronica da HBV: momenti influenti nella storia naturale, in "Le epatiti croniche virali. Storia naturale e terapia" (Giusti G., Piccinino F., Galanti B., Gaeta G.B.) (pp. 19-27). Masson, Milano.
10. Giusti, G. (1994), Le epatiti croniche virali, in "L'interferone nelle epatiti croniche" (Piccinino F., Sagnelli E., Felaco F.M., Giusti G.) (pp. 17-28). CNR Progetto FATMA, Rotoform, Roma.
11. Giusti, G., Russo, M., Galante, D. et al. (1992), Le epatiti croniche virali, in "Le epatiti croniche virali. Storia naturale e terapia" (Giusti G., Piccinino F., Galanti B., Gaeta G.B.) (pp. 37-51). Masson, Milano.
12. Hadziyannis, S., Bramou, T., Makris, A. et al. (1990), Interferon alpha-2b treatment of HBeAg negative/serum HBV-DNA positive chronic active hepatitis type B. J. Hepatol., 11, S133.
13. Hoofnagle, J.H. (1992), Interferon therapy of viral hepatitis, in "Interferon principles and medical applications" (Baron S., Coppenhaver D.H., Dianzani F. et al.) (pp. 433-462). The University of Texas Medical Branch at Galveston, Department of Microbiology, Galveston, Tx.
14. Hoofnagle, J.H. (1989), Type D (delta) hepatitis. JAMA, 261, 1321.
15. Hoofnagle, J.H., Peters, M., Mullen, K.D. et al. (1988), Randomized controlled trial of recombinant human alpha interferon in patients with chronic hepatitis B virus infection. Gastroenterology, 95, 1318.
16. Hopf, U., Moller, B., Kutther, D. et al. (1990), Long term follow up of posttransfusion and sporadic chronic hepatitis nA-nB and frequency of circulating antibodies to hepatitis C virus (HCV). J. Hepatol., 10, 69-76.
17. Mita, E., Hayashi, N., Hagiwara, H. et al. (1994), Predicting interferon therapy efficacy from hepatitis C virus genotype and RNA titer. Dig. Dis. Sci., 39, 977-982.
18. Piccinino, F., Felaco, F.M., Aprea, L. et al. (1993), Non responders to interferon therapy among chronic hepatitis patients infected with hepatitis C virus. Arch. Virol., S8, 257-263.
19. Piccinino, F., Felaco, F.M., Messina, V. et al. (1996), Multiwell: targeting the therapeutic regimen in the clinical practice. Atti del Convegno "IX triennal International Symposium on Viral Hepatitis and Liver Diseases", Roma 21-25 Aprile 1996, Abs D209, p. 331.
20. Piccinino, F., Pasquale, G., Gallo, C. et al. (1990), Comparison of clinical examination, ultrasound investigation and liver histology in the diagnosis of chronic liver disease, in "Systematic and quantitative hepatology: pathophysiological and methodological aspects" (G.P. Molino, P. Avagnina) (pp. 199-204). Masson (Milano).
21. Piccinino, F., Pasquale, G., Scolastico, C., Piccinino, R. & Glielmo, A. (1994), Correlazioni tra anticorpi anti-HCV (RIBA II) ed aspetti clinici, istologici e bioumorali in 305 pazienti con epatite cronica da HCV. Le Infezioni in Medicina, 2, 135-141.
22. Pontisso, P., Ruvoletto, M.G., Nicoletti, M. et al. (1995), Distribution of three major hepatitis C genotypes in Italy. A multicentre study of 495 patients with chronic hepatitis C. J. Viral Hepatitis, 2, 33-38.
23. Poynard, T., Bedossa, P., Chevallier, M. et al. (1995), A comparison of three alpha-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. N. Engl. J. Med., 332, 1457-1462.
24. Rizzetto, M., Verme, G., Recchia, S. et al. (1983), Chronic hepatitis in carriers of hepatitis B surface antigen, with intrahepatic expression of the delta antigen: an active and progressive disease unresponsive to immunosuppressive treatment. Ann. Intern. Med., 98, 437.
25. Rosina, F., Pintus, C., Maschievitz, C. et al. (1991), Long term interferon treatment of chronic delta hepatitis: a multicentre Italian study, in "The hepatitis delta virus" (Gerin J.L., Purcell R.H., Rizzetto M.) (p. 393). Wiley-Liss Inc. New York, USA.
26. Simmonds, P., Holmes, E.C., Cha, T.A. et al. (1993), Classification of hepatitis C virus into 6 majors genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J. Gen. Virol., 74, 2391-2399.
27. Tobler, L.H., Bush, M.P., Wilber, J. et al. (1994), Evaluation of indeterminate c22-3 reactivity in volunteer blood donors. Transfusion, 34, 130-134.
28. Tsubota, A., Chayama, K., Arase, Y. et al. (1993), Factors useful in predicting the response to interferon therapy in chronic hepatitis C. J. Gastroenterology Hepatology, 8, 535-539.
29. Yun, Z.B., Lind, G.H., Weiland, O. et al. (1993), Detection of hepatitis C virus (HCV) RNA by PCR related to HCV antibodies in serum and liver histology in Swedish blood donors. J. Med. Virol., 39, 57-61.